Stay updated with breaking news from Repligen Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Wall Street brokerages expect that Repligen Co. (NASDAQ:RGEN – Get Rating) will post $183.55 million in sales for the current fiscal quarter, Zacks Investment Research reports. Six analysts have provided estimates for Repligen’s earnings, with the lowest sales estimate coming in at $171.50 million and the highest estimate coming in at $193.21 million. Repligen posted […]
Wall Street analysts expect that Repligen Co. (NASDAQ:RGEN – Get Rating) will announce earnings per share (EPS) of $0.72 for the current quarter, Zacks Investment Research reports. Six analysts have provided estimates for Repligen’s earnings, with the highest EPS estimate coming in at $0.76 and the lowest estimate coming in at $0.66. Repligen posted earnings […]
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
IFP Advisors Inc decreased its holdings in Repligen Co. (NASDAQ:RGEN – Get Rating) by 91.7% in the fourth quarter, HoldingsChannel.com reports. The firm owned 126 shares of the biotechnology company’s stock after selling 1,398 shares during the quarter. IFP Advisors Inc’s holdings in Repligen were worth $35,000 at the end of the most recent reporting […]
LRT Capital Management LLC purchased a new stake in Repligen Co. (NASDAQ:RGEN – Get Rating) during the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 16,710 shares of the biotechnology company’s stock, valued at approximately $4,425,000. Repligen makes up approximately 3.4% of LRT Capital Management LLC’s holdings, making the stock its 9th biggest holding. […]